Literature DB >> 26875715

[Expression of G-CSF and clinical pathological significance in cervical cancer].

Hongyan Du1, Haiyan Zhang, Yu Zhang, Qiaoge Wang.   

Abstract

OBJECTIVE: To observe the expression of granulocyte colony-stimulating factor (G-CSF) in cervical cancer and to investigate its clinical significance.
METHODS: A total of 53 cases of cervical cancer with a large number of granular cell infiltration were collected in the last ten years, and 57 cases of cervical cancer with no cell infiltration were selected as controls. The infiltration of neutrophils in cancer tissues was observed, and the expression of G-CSF in cancer tissue was detected by immunohistochemistry at the same time. And the relationship between the expression of G-CSF and clinical pathological significance in cervical cancer was analyzed. All the patients were followed up, and the effect of G-CSF on the prognosis of the patients was analyzed.
RESULTS: Expression of G-CSF was observed in 53 cases out of the 110 cases cervical cancer. Among them, 48 (90.6%) cases were squamous cell carcinoma, 5(9.4%) cases were adenocarcinoma. The expression of G-CSF was closely related to granulocyte infiltration, histological type, necrosis, high grading and regional lymph node metastasis (P<0.01), but not related to size of tumor (P>0.05). G-CSF positive cases were 33.676 and 78.495 times more dangerous than those cases that were negative in high grading and regional lymph node metastasis (P<0.01). The difference in survival between the positive and the negative was also significant (P<0.01).
CONCLUSIONS: Certain cervical cancer can produce G-CSF, and the most common in non-keratinizing squamous cell carcinoma. Cervical cancer tissue that excretes G-CSF tends to have low differentiation, obvious dysplasia, high degree of malignancy, extensive necrosis and granulocyte cell infiltration, and is often associated with lymph node metastasis, with low survival rate and poor prognosis.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26875715     DOI: 10.3760/cma.j.issn.0376-2491.2016.05.009

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Za Zhi        ISSN: 0376-2491


  2 in total

Review 1.  The dark side of granulocyte-colony stimulating factor: a supportive therapy with potential to promote tumour progression.

Authors:  Belinda Yeo; Andrew D Redfern; Kellie A Mouchemore; John A Hamilton; Robin L Anderson
Journal:  Clin Exp Metastasis       Date:  2018-07-02       Impact factor: 5.150

Review 2.  Imaging findings of granulocyte colony-stimulating factor-producing tumors: a case series and review of the literature.

Authors:  Shigeshi Kohno; Akihiro Furuta; Shigeki Arizono; Koji Tokunaga; Sei Nakao; Masahiro Tanabe; Tatsuki R Kataoka; Hiroyoshi Isoda; Kaori Togashi
Journal:  Jpn J Radiol       Date:  2021-05-22       Impact factor: 2.374

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.